Aprogen, Inc
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
007460 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 중원구 둔촌대로 545 경기도 성남시 중원구 둔촌대로545, 비1층 (상대원동, 한라시그마밸리), 성남시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Aprogen, Inc. is a biopharmaceutical company specializing in the development and manufacturing of biologics. Leveraging proprietary technologies in antibody and recombinant protein engineering, the company creates both novel drugs and biosimilars. Its product pipeline focuses on addressing various medical needs, including treatments for degenerative arthritis and triple-negative breast cancer. Aprogen develops its own portfolio of biologics alongside biosimilar products, aiming to make advanced medicines more accessible in the global pharmaceutical market.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Aprogen, Inc and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Aprogen, Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Aprogen, Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
